Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

about

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

Item

http://www.wikidata.org/entity/Q54996710

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@en

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@nl

type

Item

label

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@en

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@nl

prefLabel

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@en

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.

@nl

P1476

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome

@en

P2093

Chris H Bangma

http://www.w3.org/2001/XMLSchema#string

Daan Nieboer

http://www.w3.org/2001/XMLSchema#string

Monique J Roobol

http://www.w3.org/2001/XMLSchema#string

Nuno Pereira-Azevedo

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of complications of prostate biopsy

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

A calibration hierarchy for risk models was defined: from utopia to empirical data.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Quality-of-life effects of prostate-specific antigen screening.

Advanced methods in meta-analysis: multivariate approach and meta-regression.

Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.

P304

18-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2017.12.21

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan Verbeek

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29594016

http://www.w3.org/2001/XMLSchema#string

P932

5861294

http://www.w3.org/2001/XMLSchema#string